Xilio Therapeutics, Inc. (XLO)

7.86 -0.04 (-0.51%) USD  |  NASDAQ  |  May 07, 13:24
More

Xilio Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for XLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Verastem, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade